What Are the Treatment Options for a PI-RADS 4 Lesion?

A PI-RADS 4 result means the MRI found a spot that is likely, but not certain, to be cancer. So the first step is a biopsy to find out what the spot actually is, not treatment. If it does turn out to be a cancer worth treating, men today have a wider range of choices than ever, from careful monitoring to treating only the one spot instead of the whole prostate.

What a PI-RADS 4 Score Tells You About Cancer Risk

PI-RADS is a 1-to-5 score that radiologists give each suspicious spot on a prostate MRI, with 5 the most suspicious. In one group of men, significant cancer, meaning the kind likely to grow and need attention, was found in about 10% of PI-RADS 1–2 spots, 20% of PI-RADS 3, 65% of PI-RADS 4 and 80% of PI-RADS 5.¹ Across many studies combined, about 49% of PI-RADS 4 lesions proved to be significant cancer and about 67% showed some cancer.²

The MRI shows a picture of tissue, not cells, so the radiologist is judging how suspicious the spot looks. Only a biopsy sample examined under a microscope can say what the tissue is. Inflammation or benign enlargement can look similar to cancer on MRI, which is one reason a share of PI-RADS 4 spots are harmless.

Size shifts the odds. PI-RADS 4 spots larger than about 8.5 mm carried about twice the risk of significant cancer of smaller ones.³ Doctors can also combine the MRI score with PSA, age and other tests to estimate risk more precisely.⁴ These tools support the biopsy rather than replace it for most men. Write down your lesion’s size and location so you can ask about them.

The Biopsy Comes First

A targeted biopsy aims needles at the MRI spot, while a systematic biopsy takes samples in a standard pattern across the whole gland. Using either method alone found significantly less significant cancer than combining the two.⁵ In one group, targeted biopsy alone missed significant cancer in about 2% of men with PI-RADS 4 spots.⁶ It is reasonable to ask whether your biopsy will include both targeted samples and the standard pattern of samples.

The combination matters for treatment choice too. Relying on targeted samples alone can make a cancer look higher-grade than it really is, which could steer some men toward treatment when monitoring would have been reasonable.⁷

Before the biopsy, the MRI images are loaded into the biopsy equipment so the doctor can see where the spot lies in the gland and steer needles to it. This is often called a fusion biopsy because the MRI image is overlaid on live ultrasound images. Another approach is to do the biopsy while you are inside the MRI scanner. Either way, several samples are usually taken from the spot itself so a small cancer within it is less likely to be missed.

The biopsy is usually done as an outpatient procedure under local or general anesthesia. Needles go through the skin between the legs or through the rectum. Expect some blood in your urine or semen for days afterward. Results generally take about a week or two.

If Your Biopsy Comes Back Negative

Needles can miss a small spot, so men with a PI-RADS 4 lesion and a negative biopsy should be considered for a repeat biopsy or strict monitoring.⁸ A negative result is more reassuring when the needles were clearly aimed at the spot and several samples were taken from it, and less reassuring when the spot was hard to reach. Benign findings such as inflammation can sometimes explain the MRI spot, and your doctor may judge that a plausible reason.

Experts suggest having the MRI re-read and following up with repeat MRI, saving repeat biopsy for the highest-risk men.⁹ The re-read means the radiologist looks at the original images again, knowing the biopsy result, to judge whether the needles landed on the spot. If the spot now looks less suspicious, the plan may shift toward watching it. If it still looks suspicious and the needles may have missed, a repeat targeted biopsy becomes more likely.

Location matters. Clear spots in the outer prostate usually warrant a repeat targeted biopsy, while spots in the central zone with signs of benign enlargement may be followed with a repeat MRI first.¹⁰ A rising PSA pushes toward another biopsy. Keep the follow-up date, because a negative result is not an all clear.

How Your Biopsy Results Shape the Options

Your pathology report will give a Gleason score or Grade Group, from 1 (slowest) to 5 (most aggressive). Grade Group 1 cancers are the kind most often suited to monitoring. Grade Groups 2 and 3 sit in the middle, and doctors often weigh how much of the sample shows the more aggressive pattern. Grade Groups 4 and 5 usually call for active treatment rather than watching. When you read your report, look for the Grade Group and how many cores held cancer, note what percent of each core was cancer, and ask which risk group (low, intermediate or high) you fall in.

PSA density, your PSA divided by prostate size, adds to the picture. A PSA density of 0.15 or more for low MRI scores, and 0.10 or more for PI-RADS 3 and up, was linked to more aggressive disease found at surgery.¹¹ The cancer’s grade on biopsy is not final: it changed after surgery in about 1 in 4 men, though it changed enough to matter in only about 1 in 10.¹² A PI-RADS 4 or higher score was also linked to roughly twice the chance of PSA returning after surgery.¹³

Some tests also analyze genes in the biopsy tissue. They help predict whether the cancer will behave aggressively, which can help decide between monitoring and treatment.

Active Surveillance Watching Instead of Treating

Active surveillance means regular checks, with treatment only if the cancer shows signs of growing. For Grade Group 2 cancer, men with only small amounts of the more aggressive pattern, about 10% or up to 15%, and low PSA density were reliable candidates.¹⁴ For low-risk men under 70, a yearly MRI with biopsy only when a spot scores 4 or higher gave the same life expectancy as more frequent biopsy, with 42% fewer biopsies.¹⁵

A typical schedule has PSA tests every few months and an MRI about once a year, with a biopsy when the MRI or PSA suggests change. Switching to treatment is always an option.

To decide when to switch, doctors usually look for a higher grade on repeat biopsy, a larger lesion on MRI, or a PSA that keeps rising. Most men who switch do so because of a test result, not symptoms, since early prostate cancer often causes none.

Whole-Gland Treatment With Surgery or Radiation

Radical prostatectomy removes the whole prostate, now usually by robot-assisted surgery. The surgeon also takes the small glands next to the prostate, and may remove nearby lymph nodes depending on risk. The bladder is then joined to the urethra, which is why a catheter is needed while the join heals. The removed tissue goes to a pathologist, who can report the true grade and whether the cancer reached the edges.

Recovery usually means a urinary catheter for about a week. Leakage usually improves over months, and pelvic floor exercises help control return.

Radiation can be given over several weeks, in a few high-dose sessions, or by implanting radioactive seeds. After a short, high-dose course, most cancer that remained was found in the original PI-RADS 4 or 5 spot.¹⁶ So doctors may boost the dose to that spot, since higher doses and hormone therapy lowered the chance of cancer remaining.¹⁷

Surgery gives a full tissue report on the cancer, while radiation avoids an operation and hospital stay. Hormone therapy is sometimes added to radiation. Age and other health problems often steer the choice.

Focal Therapy Treating Only the Lesion

Focal therapy treats only the lesion and leaves the rest of the prostate alone. Options include freezing, focused ultrasound heat, laser, electric pulses and targeted radiation seeds, mainly for intermediate-risk men.¹⁸ Freezing destroys tissue with extreme cold delivered through thin probes placed in the lesion. Focused ultrasound uses sound waves aimed to heat and destroy an area without any incision. Electric-pulse treatment uses short pulses through fine needles to damage cells in the zone while aiming to spare nearby structures.

Single-session targeted radiation has been tried for men with one PI-RADS 4 or 5 lesion and low to intermediate risk.¹⁹ After electric-pulse treatment, follow-up biopsies found the treated area cancer-free in about 88%.²⁰ But significant cancer appeared elsewhere in the prostate in about 1 in 8 men.²¹ So focal therapy requires repeat MRI and biopsy, and some men later need further treatment.

It is typically a same-day procedure. Long-term cancer control data are still limited, and it may not be offered everywhere or covered by every insurer. If it is offered, ask how many cases the team has done, what the follow-up biopsy schedule is, and what happens if cancer returns.

Side Effects Compared Across Treatments

In the first 5 years, surgery caused more leakage and erection problems, while radiation caused more bowel problems.²² By 15 years, these differences mostly evened out.²³ Focal therapies kept about 94–100% of men free of pads and about 47–86% able to have intercourse.²⁴ At 2 years, about 88–89% were continent after focused ultrasound, freezing or surgery, while erection recovery was 58% after surgery, 44% after ultrasound and 38% after freezing.²⁵

The numbers vary this much because results depend on a man’s age, his baseline erections, the size and position of the cancer, and the skill of the surgeon or team. Studies also define continence and erections differently, so figures from one study are not directly comparable with another’s. Treat them as ranges, not promises, and ask any team for its own side-effect rates.

For erection problems, pills like sildenafil help many men, and injections are an option when pills fail.²⁶ Early rehabilitation may improve recovery.

Follow-Up After Treatment

After surgery, PSA should become nearly undetectable, so a rise signals possible recurrence. Combining MRI and a PSMA PET scan finds cancer returning in the prostate area better than either alone.²⁷ MRI is best at spotting cancer in the prostate bed, while PSMA PET better finds spread to lymph nodes.²⁸

Expect PSA checks every few months at first, then less often as years pass. Report urinary or bowel changes, and keep copies of your results.

After radiation, the prostate remains in place, so PSA falls slowly and does not usually reach zero. Doctors watch for a rise above the lowest level reached, not for a particular number. A temporary bump can occur after radiation without meaning the cancer has returned.